2024 CDC Pandemic Preparedness Cohorts Grant: Strengthening Respiratory Virus Monitoring Networks
The “Network of Community Cohorts for Monitoring Changes in Respiratory Virus Epidemiology (Pandemic Preparedness Cohorts)” grant, offered by the Centers for Disease Control and Prevention (CDC), is aimed at establishing a network of community-based cohorts in the United States. These cohorts will monitor changes in respiratory virus epidemiology, with a focus on diverse age groups and regions. Eligible applicants include a wide range of organizations, including state and local governments, nonprofits, for-profit organizations, and institutions of higher education. This grant is particularly suitable for entities interested in public health research and preparedness for monitoring and responding to respiratory viruses.
General Information
Document Type: | Grants Notice |
Opportunity Number: | RFA-IP-24-045 |
Opportunity Title: | Network of Community Cohorts for Monitoring Changes in Respiratory Virus Epidemiology (Pandemic Preparedness Cohorts) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | |
Expected Number of Awards: | 10 |
CFDA Number(s): | 93.083 — Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases |
Cost Sharing or Matching Requirement: | No |
Version: | Forecast 1 |
Forecasted Date: | Oct 03, 2023 |
Last Updated Date: | Oct 03, 2023 |
Estimated Post Date: | Dec 05, 2023 |
Estimated Application Due Date: | Feb 03, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Estimated Award Date: | Jul 31, 2024 |
Estimated Project Start Date: | Aug 01, 2024 |
Fiscal Year: | 2024 |
Archive Date: | Mar 04, 2024 |
Estimated Total Program Funding: | $ 100,250,000 |
Award Ceiling: | $ 20,050,000 |
Award Floor: | $ 15,035,000 |
Eligibility
Eligible Applicants: | Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) County governments Private institutions of higher education City or township governments State governments Independent school districts For profit organizations other than small businesses Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education |
Additional Information on Eligibility: |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | At the start of the COVID-19 pandemic, infrastructure for understanding the epidemiology of a rapidly evolving virus in real-time was limited. Given the long lead time required for the government to start new projects, the CDC harnessed a variety of studies and platforms designed for other purposes to begin collecting the specimen and survey data needed to understand COVID-19 risk, burden, severity, and immunity. While hospital-based platforms were key to understanding frequency and risk factors for severe disease, community-based platforms were important for understanding viral kinetics, risk factors for infection, transmission dynamics, long-term outcomes, and the impact of vaccination on each of these measures.This funding opportunity would build on the lessons learned during the COVID-19 pandemic and establish a network of community-based cohorts, including diverse age groups (target populations: younger than 5 years old, 5-17 years old, 18-64 years old, and older than 64 years old), demographic characteristics, and regions in the US, to allow ongoing monitoring of changes in respiratory virus epidemiology in the years following the COVID-19 pandemic. A consolidated network will be more efficient and cost savings than current disparate mechanism, strengthen communication/collaboration, and enhance CDC’s preparedness to quickly obtain data on infection risk, transmission, and effectiveness of preventive measures in response to a novel virus or variant. |
Link to Additional Information: | |
Grantor Contact Information: |
Dr. Amy Yang
404-718-8836
|